Alnylam 's R&D program created several treatments for rare diseases, benefitting over 3,495 patients

Alnylam Pharmaceuticals

Solutions - R&D

3: Good Health and Well-being

Written by

Abdulmajeed V. Jan 16th, 2024

Reviewed by

Luca L.

Comments

There is no comment yet.

#research #Development #genetic diseases #medicine

Actual Direct Impact

Assess the impact materiality of this Topic for Alnylam Pharmaceuticals

How negative/positive is the impact of Alnylam Pharmaceuticals for this Topic?

Share this Analysis

Alnylam Pharmaceuticals

Solutions - R&D

3: Good Health and Well-being

Written by

Abdulmajeed V. Jan 16th, 2024

Reviewed by

Luca L.

Keen to rectify an issue with this analysis?

Report issue

What are the SDGs and why use them?

The United Nations Sustainable Development Goals (SDGs) are the set of 17 goals agreed by 193 countries covering all the major impact areas we need to focus on. They are a universally recognised framework that allow governments, businesses, medias and civil society to share the same language and agree on a common set of targets to protect the planet and improve society.

At Impaakt, we use the SDGs as an analytical framework to help our contributors structure their work, and our clients compare the impact of different companies according to well-defined, standardized themes.

Usage of cookies on the Impaakt platform

Alnylam 's R&D program created several treatments for rare diseases, benefitting over 3,495 patients

Solutions - R&D

Actual Direct Impact

Assess the impact materiality of this Topic for Alnylam Pharmaceuticals

Share this Analysis

Solutions - R&D